SANIONSaniona ABSANION info
$0.47info0.53%24h
Global rank27977
Market cap$30.06M
Change 7d4.82%
YTD Performance13.93%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Saniona AB (SANION) Stock Overview

    Saniona AB (publ), a biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Denmark. It also develops medicines modulating ion channels. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which has completed Phase 1 clinical stage for neuropathic pain conditions; SAN903 for inflammatory and fibrotic disorders; and SAN2219, that is in preclinical stage for treatment of epilepsy. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS; and research collaboration with AstronauTx to identify new treatments for Alzheimer's disease. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.

    SANION Stock Information

    Symbol
    SANION
    Address
    Smedeland 26BGlostrup, 2600Denmark
    Founded
    -
    Trading hours
    -
    Website
    https://www.saniona.com
    Country
    🇩🇰 Denmark
    Phone Number
    45 70 70 52 25

    Saniona AB (SANION) Price Chart

    -
    Value:-

    Saniona AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.4687270411911642
    N/A
    Market Cap
    $30.06M
    N/A
    Shares Outstanding
    64.13M
    N/A
    Employees
    23.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org